When BIO 2019 closed its doors in Philadelphia last June, none of the delegates of the industry’s largest event would have predicted that the next meeting, scheduled for San Diego, would be ...
As life science professionals, we not only continuously handle hard science and research, but we also have to learn how to market our products and interact with a large online audience. ...
Check out this article for the impacts that Biotech Bay companies are experiencing due to COVID-19.
So let’s say you’re running a cutting-edge, clinical-stage biotech, probably public, but not necessarily so, which could see some big advantages teaming up with some marquee researchers, ...
With the close of the fund, Atlas Venture said it will continue to advance its mission of “doing well by doing good” and building biotech companies that will deliver high-impact therapies ...
After a drumbeat of failure, setbacks and reorganizations over the last few years, Aduro CEO Stephen Isaacs is handing over his largely gutted-out shell of a public company to another ...
We found out a few weeks ago that Moderna CFO Lorence Kim isn’t waiting around to see how the biotech wunderkind makes out in its frantic race to field a messenger RNA vaccine that can ...
After the deaths of George Floyd, Ahmaud Arbery, and Breonna Taylor, Americans have taken to the streets to call out racial inequalities, police violence and systemic racism. Biopharma CEOs ...